factor IX


Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Wikipedia.
Related to factor IX: factor XI

factor IX

[′fak·tər ′nīn]
(biochemistry)
References in periodicals archive ?
Neose "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation the risk that the collaboration will not continue or will not be successful, or that a next-generation version of Factor IX will not be successfully developed.
In addition to the recombinant coagulation factor IX program, GTC is developing a portfolio of recombinant human plasma proteins with known therapeutic properties.
In this study, participants received one of three doses of gene therapy that used a modified adeno-associated virus (AAV) 8 as the vector to deliver the genetic material for making Factor IX.
We look forward to our partnership as we prepare for large scale manufacturing of our Factor IX product for the treatment of hemophilia B.
Delivery of clotting factor concentrates: Item 1 - coagulation factor IX concentrate osoczopochodny delivered to the patient~s home / to the haemophilia center; item.
Biovitrum (STO:BVT) today announced it has entered into a new agreement, effective August 8, 2007, with Wyeth (NYSE:WYE) to co-promote BeneFIX[R], Coagulation Factor IX (Recombinant) for hemophilia B, in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden).
Contract awarded for 4855/2014 event factor ii, factor ix, factor vii, factor x powder & solution for parenteral use, road 500 iu
24, 2013 /PRNewswire/ -- The agreement covers the commercial manufacture of a monoclonal antibody used for the recovery and purification of coagulation factor IX from human blood.
NasdaqGM:NTEC) today announced that it received a milestone payment from Novo Nordisk A/S (NYSE:NVO) under a license agreement entered into November 2003 for the use of Neose's GlycoPEGylation[TM] technology to develop a next-generation version of Factor IX.
Contract awarded for ii factor factor ix, factor vii, factor x powder and sol.
AMSTERDAM, July 3, 2013 /PRNewswire/ -- Data presented by CSL Behring today showed clinical efficacy of a once-weekly dosing regimen of recombinant fusion protein linking coagulation Factor IX with albumin (rIX-FP).
AMSTERDAM, July 3, 2013 /PRNewswire/ -- CSL Behring today presented a population pharmacokinetic model for recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam.